US$ 21.51
divislab glp-1 novo nordisk relation A $60 billion industry just found its next growth lever. π With the expiry of a key patent on March 20, 2026, Indian pharma majors are launching generic weight-loss and diabetes drugs Novo Nordisk's Innovative Research and
Description
Here's what to know

Semaglutide has been shown to aid in weight loss by helping individuals feel fuller for longer and reducing cravings

Wondering if you can take aspirin with Wegovy

Get the latest tirzepatide cost breakdown

KaplanMeier survival analysis was performed and estimated HRs were reported for each outcome
